Alimentiv is a global Contract Research Organization (CRO) with a clear and focused strategy: advancing therapies for gastrointestinal (GI) diseases. For more than 30 years, this specialization has enabled strong scientific credibility, operational discipline, and consistent delivery—supporting over 70% of investigational IBD compounds.

We are a privately held, profit-with-purpose organization, committed to responsible growth and the disciplined reinvestment of capital into innovation, systems, and our people. With approximately 700 employees across multiple countries and three established service lines, we offer both the scale of a global organization and the agility of a focused specialist.

• For accounting and finance professionals, Alimentiv offers the opportunity to contribute to a business where financial stewardship, transparency, and performance directly support long-term value creation. Our finance teams are critical partners in guiding sustainable growth, strengthening operational effectiveness, and ensuring that our investments continue to drive both business performance and meaningful clinical impact.